
Apollo acquires €3bn stake in Bayer contraceptives business
Apollo Global Management has agreed to acquire a minority stake in Bayer’s long-acting reversible contraceptives business for €3bn, in a transaction that highlights the private capital firm’s growing role as a provider of large-scale strategic financing to multinational corporations, according to a report by Bloomberg.


